Literature DB >> 20042003

Granulocytes: effector cells or immunomodulators in the immune response to helminth infection?

E T Cadman1, R A Lawrence.   

Abstract

Granulocytes are effector cells in defence against helminth infections. We review the current evidence for the role of granulocytes in protective immunity against different helminth infections and note that for each parasite species the role of granulocytes as effector cells can vary. Emerging evidence also points to granulocytes as immunomodulatory cells able to produce many cytokines, chemokines and modulatory factors which can bias the immune response in a particular direction. Thus, the role of granulocytes in an immunomodulatory context is discussed including the most recent data that points to an important role for basophils under this guise.

Entities:  

Mesh:

Year:  2010        PMID: 20042003     DOI: 10.1111/j.1365-3024.2009.01147.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  16 in total

Review 1.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

Review 2.  The Eosinophil in Infection.

Authors:  Karen A Ravin; Michael Loy
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 3.  Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.

Authors:  Vivekanandhan Aravindhan; Gowrishankar Anand
Journal:  Am J Trop Med Hyg       Date:  2017-10-26       Impact factor: 2.345

4.  Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice.

Authors:  Amy E O'Connell; Jessica A Hess; Gilberto A Santiago; Thomas J Nolan; James B Lok; James J Lee; David Abraham
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

Review 5.  Vesicular trafficking of immune mediators in human eosinophils revealed by immunoelectron microscopy.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  Exp Cell Res       Date:  2016-08-22       Impact factor: 3.905

6.  Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen.

Authors:  R Shimogawara; N Hata; A Schuster; H Lesshafft; S Guedes de Oliveira; R Ignatius; N Akao; N Ohta; H Feldmeier
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

7.  Eosinophils are important for protection, immunoregulation and pathology during infection with nematode microfilariae.

Authors:  Emma T Cadman; Katherine A Thysse; Siobhan Bearder; Anita Y N Cheung; Ashleigh C Johnston; James J Lee; Rachel A Lawrence
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

8.  Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo.

Authors:  Derek K Chu; Rodrigo Jimenez-Saiz; Christopher P Verschoor; Tina D Walker; Susanna Goncharova; Alba Llop-Guevara; Pamela Shen; Melissa E Gordon; Nicole G Barra; Jennifer D Bassett; Joshua Kong; Ramzi Fattouh; Kathy D McCoy; Dawn M Bowdish; Jonas S Erjefält; Oliver Pabst; Alison A Humbles; Roland Kolbeck; Susan Waserman; Manel Jordana
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

9.  CD4 T-cell hyporesponsiveness induced by schistosome larvae is not dependent upon eosinophils but may involve connective tissue mast cells.

Authors:  C T Prendergast; D E Sanin; A P Mountford
Journal:  Parasite Immunol       Date:  2016-02       Impact factor: 2.280

10.  Reduced Leukocyte Infiltration in Absence of Eosinophils Correlates with Decreased Tissue Damage and Disease Susceptibility in ΔdblGATA Mice during Murine Neurocysticercosis.

Authors:  Pramod K Mishra; Qun Li; Luis E Munoz; Chris A Mares; Elizabeth G Morris; Judy M Teale; Astrid E Cardona
Journal:  PLoS Negl Trop Dis       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.